Researchers from Georgia State University and Georgia Institute of Technology have developed a novel type of protein nanoparticle vaccine formulation containing influenza proteins and adjuvant that provided complete protection against influenza viral infections. The protein nanoparticle consists of the influenza nucleoprotein as the core and surface proteins as the coating antigens. The researchers have focused their work on developing different types of protein nanoparticle vaccines against both influenza A and influenza B viral infections.
An official website of the United States government.